CTLA4:B7-1[Biotinylated] Inhibitor Screening Assay Kit

Catalog #
72009
$1,125 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The CTLA4:B7-1[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of CTLA4:B7-1 signaling. The key to this kit is the high sensitivity of detection of biotin-labeled B7-1 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, CTLA4 is coated on a 96-well plate. Next, B7-1 is incubated with CTLA4 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can be measured using a chemiluminescence reader.

This product has been cited 4 times.

Synonyms
Cytotoxic T-lymphocyte-associated protein 4, CD152, CTLA-4 Counter-Receptor, B7.1, CD80, activity assay kit, Strep HRP, streptavidin, CTLA-4
Product Info
Storage and Usage
Citations4
Assay Kit Format
Chemiluminescent
Supplied As
This kit comes in a convenient 96-well format, with biotin-labeled B7-1, purified CTLA4, streptavidin-labeled HRP, and assay buffer for 100 binding reactions.
Format

Catalog #

Component

Amount

Storage

71114

B7-1, Biotin-labeled

5 µg

-80°C

Avoid
freeze/
thaw
cycles!

71149

CTLA4

10 µg

-80°C

79742

Streptavidin-HRP

10 µl

+4°C

79311

3x Immuno Buffer 1

50 ml

-20°C

79728

Blocking Buffer 2

50 ml

+4°C

79670

ELISA ECL substrate A (transparent bottle)

6 ml

+4°C

ELISA ECL substrate B (brown bottle)

6 ml

+4°C

79699

White 96-well microplate 

1

+4°C

UniProt #
P33681
Background
The activation of naïve T cells requires two signals, the specific T cell receptor recognition of MHC/Antigen on the surface of the antigen-presenting cell (APC), and the binding of B7-1 (CD80) ligand on the APC with the CD28 receptor on the T cell surface. Conversely, binding of CTLA4 to B7-1 on the T-cell surface results in an inhibitory signal and prevents T-cell activation. CTLA4:B7-1 interaction is an important drug target for the regulation of the host’s response to cancer.
References

1. Linsley, P.S., et al. J. Exp. Med. 1991, 174(3): 561-569.
2. Hurwitz, A.A., et al. Canc. Res. 2000, 60: 2444-2448.